Vertex Pharmaceuticals (NasdaqGS:VRTX) announced that its cystic fibrosis treatment, ALYFTREK®, had received regulatory approval from the UK's MHRA, a significant milestone in expanding its market ...

As U.S. markets grapple with the implications of newly imposed tariffs and economic uncertainties, investors are increasingly seeking opportunities in undervalued stocks that may offer intrinsic value ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

LONDON, February 28, 2025--Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a ...

EDIT stock is down following the announcement of dismal fourth-quarter 2024 results as both earnings and revenues miss estimates.

Qureator, a leading AI-powered human disease model company, today announced the appointment of Dr. Branka Mitrovic as its new Chief Scientific Officer (CSO). Dr. Mitrovic brings extensive experience ...

Here's why four Motley Fool contributors think chip giants Nvidia ( NVDA -0.26%) and Micron Technologies ( MU -1.05%), travel ...

At close: March 5 at 9:45:34 PM GMT+1 ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

This writer digs into the CRISPR gene-editing space, asking whether one particular penny stock is worth taking a punt on in ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.